How often have you pulled out old MCU-based project that still works fine, but you have no idea where the original source ...

Qualcomm and Arduino unleash VENTUNO Q that lets AI move offline ...

With VENTUNO Q, AI can finally move from the cloud into the physical world. This platform makes it possible to build machines that perceive, decide, and act — all on a single ...

Named after the Italian word for twenty-one​, VENTUNO Q builds on the iconic legacy of the popular Arduino® UNO™ family and embodies the company’s coming of age as it prepares to celebrate its ...

Five months after acquiring Arduino, the open-source hardware and software company best known for its UNO and Nano microcontroller board for hobbyists, Qualcomm is looking to make another big splash ...

GameSpot may get a commission from retail offers. When Barbarian and Weapons director Zach Cregger signed on to helm the next Resident Evil movie, it was described as "a revamp that will take the ...

Qualcomm, which purchased microcontroller board manufacturer Arduino last year, just announced a new single-board computer that marries AI with robotics. Called the Arduino Ventuno Q, it uses Qualcomm ...

Qualcomm’s Arduino has announced the upcoming launch of Arduino VENTUNO Q, a platform designed for edge AI, robotics, and ...

Last year, Qualcomm acquired Arduino, a company known for its tinker-friendly microcontroller kits and single board computers (SBC). The first product to follow was the Uno Q, which was powerful ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...